Categories: Short News

Nurtec ODT Now Approved to Help Prevent Episodic Migraine, Too

Nurtec ODT (rimegepant) was first approved in February 2020 by the U.S. Food and Drug Administration (FDA) for the acute treatment of migraine in adults. Now, the FDA has given the green light to Nurtec ODT to help prevent episodic migraines, too — making it the first migraine medication approved for both acute and preventive treatment.
Medlarge

Recent Posts

Diarrhea main killer of kids under 5, adults above 70: Study

Diarrhea remains one of the leading killers of children under five and the elderly, particularly…

2 days ago

Healthy population fuels productivity, drives economic growth: Union Health Secretary

Union Health Secretary Punya Salila Srivastava on Thursday said that healthcare is not only a…

2 days ago

NEET-UG exam soon to shift from offline to online, NTA to undergo re-structuring

Union Education and Health ministries are working on a proposal to switch the medical entrance…

5 days ago

Metropolis Healthcare introduces Innovative Blood Collection Technology

In an effort to improve the patient experience, Ameera Shah-led Metropolis Healthcare Limited, India’s second-largest…

5 days ago